Enterprise Value
213.1M
Cash
24.6M
Avg Qtr Burn
-4.20M
Short % of Float
4.08%
Insider Ownership
60.34%
Institutional Own.
15.00%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NXP800 Details Ovarian cancer, Cancer | Phase 1b Data readout | |
NXP900 Details Cancer, Squamous cancers, Solid tumor/s | Phase 1a Data readout |